In particular, the conference will focus on the biology of existing host cells (in terms of competencies for protein expression), structural features associated with success of expression of specific proteins (including the relationships between specific proteins and host cells) and how both host cell and desired proteins may be engineered to generate new (synthetic) systems for enhanced product expression. The two day conference will consist of presentations by plenary speakers, workshop sessions with invited speakers and speakers selected from offered abstracts and a poster session. Participation will be strictly limited to 220 attendees to enable networking and informal discussion.
Confirmed Plenary Speakers:
Evolving stable and well expressing GPCRs for structure determination and drug screening
CHO genome engineering to decrease transcriptional and protein processing bottlenecks
Nicolas Mermod, University of Lausanne
Systems Biology for improving production of cellular products
Pedro Mendes, University of Manchester
Correct protein folding in the ER is driven through mitochondrial function
Randy Kaufman, Sanford-Burnham Medical Research Centre, La Jolla
Maximizing recombinant protein expression through systematic gene design
Claes Gustafsson, DNA 2.0, San Francisco
Book your stand at the AstraZeneca Conference Centre Here: http://www.elrig.org/bookings//AIRPT13/
Call for Abstracts – Deadline July 29th
Send in your talks for a potential Podium Presentation: Submit a Talk Title, brief summary and your contact details to speakers@elrig.org
Submit an Abstract to: posters@elrig.org
Mark your Abstract with the ‘Recombinant Protein Technology’ show . Topic areas: Proteins OR Cells